Salmon lice drug secures new funding
Norwegian biotech company Vestland Pharma, which has patented a drug against salmon lice, has received fresh backing, with venture company Sarsia and the seafood company Coast Seafood becoming shareholders.
Norwegian biotech company Vestland Pharma, which has patented a drug against salmon lice, has received fresh backing, with venture company Sarsia and the seafood company Coast Seafood becoming shareholders.
Related Articles
AQUACULTURE
AQUACULTURE
AQUACULTURE